Thromb Haemost 1996; 75(02): 292-297
DOI: 10.1055/s-0038-1650263
Original Article
Schattauer GmbH Stuttgart

Plasma Ascorbate Protects Coagulation Factors against Photooxidation

Jaakko Parkkinen
The Finnish Red Cross Blood Transfusion Service, Helsinki, Finland
,
Outi Vääränen
The Finnish Red Cross Blood Transfusion Service, Helsinki, Finland
,
Elina Vahtera
The Finnish Red Cross Blood Transfusion Service, Helsinki, Finland
› Author Affiliations
Further Information

Publication History

Received: 19 September 1995

Accepted after revision07 November 1995

Publication Date:
26 July 2018 (online)

Summary

It has been suggested that proteins, unlike lipids, are not protected against oxidative damage by antioxidants in plasma. We have studied the effect of photodynamic virus inactivation treatment of fresh human plasma on coagulation factor activities. Photodynamic treatment generates singlet oxygen which causes inactivation of fibrinogen and factor VIII. Other coagulation factors or anticoagulant proteins are clearly less affected. We found that there is an inverse correlation between the extent of coagulation factor inactivation during the treatment and the plasma ascorbate concentration. The inactivation of coagulation factors was prevented in a dose-dependent manner by adding ascorbate to the plasma before the treatment. Ascorbate was consumed during the treatment at an apparently linear rate. Oxidation of urate and coagulation factors was enhanced when ascorbate had disappeared from plasma. These results indicate that ascorbate is a primary antioxidant against photooxidation in plasma and that it effectively prevents oxidative damage to coagulation factors and other proteins.

 
  • References

  • 1 Laustriat G. Molecular mechanism of photosensitization. Biochimie 1986; 68: 771-778
  • 2 Foote CS. Mechanism of photosensitized oxidation. Science 1968; 162: 963-970
  • 2 Mathews-Roth MM. Beta-carotene therapy for erythropoietic protoporphyria and other photosensitivity diseases. Biochimie (Paris) 1986; 68: 875-884
  • 4 Halliwell B, Gutteridge JMC. Free radicals in biology and medicine. 2nd ed Oxford Univ Press; Oxford: 1989
  • 5 Murphy ME, Sies H. Visible-range low-level chemiluminescence in biological systems. Methods Enzymol 1990; 186: 595-610
  • 6 Kanofsky JR, Hoogland H, Wever R, Weiss SJ. Singlet oxygen production by human eosinophils. J Biol Chem 1988; 263: 9692-9696
  • 7 Steinbeck MJ, Khan AU, Kamovsky MJ. Intracellular singlet oxygen generation by phagocytosing neutrophils in response to particles coated with a chemical trap. J Biol Chem 1992; 267: 13425-13433
  • 8 Levy JG. Photodynamic therapy. Trends Biotechnol 1995; 13: 14-18
  • 9 Matthews JL, Newman JT, Sogandares-Bemal F, Judy MM, Skiles H, Leveson JE, Marengo-Rowe AJ, Chanh TC. Photodynamic therapy of viral contaminants with potential for blood banking applications. Transfusion 1988; 28: 81-83
  • 10 Lambrecht B, Mohr H, Kniiver-Hopf J, Schmitt H. Photoinactivation of viruses in human fresh plasma by phenothiazine dyes in combination with visible light. Vox Sang 1991; 60: 207-212
  • 11 Wagner JR, Motchnik PA, Stocker R, Sies H, Ames BN. The oxidation of blood plasma and low density lipoprotein components by chemically generated singlet oxygen. J Biol Chem 1993; 268: 18502-18516
  • 12 Frei B, England L, Ames BN. Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci 1988; 85: 9748-9752
  • 13 Hardisty RM, Macpherson JC. A one-stage factor VIII (antihaemophilic globulin) assay and its use on venous and capillary plasma. Thromb Diathes Haemorrh 1962; 7: 215-229
  • 14 Martinoli JL, Stocker K. Fast functional protein C assay using Protac, a novel protein C activator. Thromb Res 1986; 43: 253-264
  • 15 Hjort PF. Scand. J Clin Lab Invest 1957; (Suppl. 09) suppl 27
  • 16 Parviainen MT, Nyyssonen K, Penttila IM, Seppanen K, Rauramaa R, Salonen JTS, Gref C-G. A method for routine assay of plasma ascorbic acid using high-performance liquid chromatography. J Liq Chromatogr 1986; 9: 2185-2197
  • 17 Berckmans RJ, Boer P. An inexpensive method for sensitive enzymatic determination of oxalate in urine and plasma. Clin Chem 1988; 34: 1451-1455
  • 18 Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959; 82: 70-77
  • 19 Ames BN, Cathcart R, Schwiers E, Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci 1981; 78: 6858-6862
  • 20 Frei B, Stocker R, Ames BN. Antioxidant defences and lipid peroxidation in human blood plasma. Proc Natl Acad Sci 1988; 85: 9748-9752
  • 21 Inada Y, Hessel B, BlombackE B. Photooxidation of fibrinogen in the presence of methylene blue and its effect on polymerization. Biochem Biophys Acta 1978; 532: 161-170
  • 22 Shimizu A, Saito Y, Matsushima A, Inada Y. Identification of an essential histidine residue for fibrin polymerization. Essential role of histidine 16 of Bp-chain. J Biol Chem 1983; 258: 7915-7917
  • 23 Dean RT, Giesseg S, Davies M. Reactive species and their accumulation on radical-damaged proteins. Trends Biotechnol 1993; 18: 437-441
  • 24 Lentner C. ed Geigy Scientific Tables, CIBA-Geigy, Basel 1981, Vol 1 180
  • 25 Wieding JU, Hellstem P, Kohler M. Inactivation of viruses in fresh-frozen plasma. Ann Hematol 1993; 67: 259-266
  • 26 Zeiler T, Riess H, Wittmann G, Hintz G, Zimmermann R, Muller C, Heuft HG, Huhn D. The effect of methylene blue phototreatment on plasma proteins and in vitro coagulation capability of single-donor fresh-frozen plasma. Transfusion 1994; 34: 685-689